Suraksha Diagnostic's IPO received a lukewarm response with only 25% subscription by the second day. The structure, being an Offer for Sale, means the company won't gain any proceeds, leading analysts to advise against investing. The price band is set at Rs 420-441 per share, with allotment finalizing on December 4 and listing on December 6.
